Newsletter Subject

Futures down on mixed bank earnings 📉

From

elitetrade.club

Email Address

adam@elitetrade.club

Sent On

Fri, Apr 12, 2024 12:50 PM

Email Preheader Text

Wall Street's biggest banks just kicked off the beginning of the financial sector's headline earning

Wall Street's biggest banks just kicked off the beginning of the financial sector's headline earnings season, and the early results have been a mixed bag.                                                                                                                                                                                                                                                                                                                                                                                                                 April 12, 2024 | [Read Online]( Good Morning! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Let’s get ready to trade! Markets 📈 Stocks returned to form on Thursday with modest gains for most indexes. The Dow ended the day close to flat, while the Nasdaq outperformed. - Dow [<0.1%] - S&P 500 [+0.7%] - Nasdaq [+1.6%] - Russell 2K [+0.7%] Indexe futures are pointing lower in early premarket trading. S&P 500 contracts are down 0.2%. What to Watch Today: Bank earnings kick off today with reports from JPMorgan, Citi, Wells Fargo, and others. The reports could hold sway over today’s session, and the market’s reaction to the numbers will most likely set the trading session. [Unlock Easy Day Trading: Join the 10-Minute Trade Revolution!]( Discover Hugh Grossman's groundbreaking "day trading" system, which simplifies trading to just a 10-minute, stress-free activity per day. This unique method involves a simple email check, an option symbol entry, and a profit target setup—no glued-to-screen hours or complex analyses required. Today, we're inviting only 87 new traders to experience this hassle-free approach to options trading. [Click here to revolutionize your trading day in just 10 minutes.]( » Want an Ad-Free Experience + Top Growth Stock Picks? [Upgrade Now!]( Premarket Highlights 🔎 🕵️ Feds Investigate Morgan Stanley Wealth Management Morgan Stanley [MS] faces probes from multiple federal regulators, including the Securities and Exchange Commission (SEC), the Office of the Comptroller of the Currency, and other Treasury Department entities. This scrutiny is an expansion of earlier investigations reported by the Federal Reserve, which has already hinted at potential supervisory actions against the bank's wealth-management division. Anti-Money Laundering 💵 The central concern of these investigations is Morgan Stanley's diligence in vetting new clients and monitoring ongoing financial activities, particularly regarding the origins of clients’ wealth and the potential for money laundering. The emphasis is notably sharp on the bank’s international clientele, raising questions about the robustness of its global compliance frameworks. Company Response 🗯️ In response to the increasing regulatory pressure, Morgan Stanley has reportedly ramped up investments in compliance, technology, and artificial intelligence to enhance oversight of its wealth management transactions. Despite these efforts, news of the broadened probe led to a sharp decline in Morgan Stanley's stock, which fell over 5% in recent trading sessions, reflecting investor concerns over the potential repercussions of these regulatory investigations. Strategic Adjustments 🔧 The ongoing scrutiny from such a wide array of regulatory bodies signals a critical period for Morgan Stanley as it strives to align its operations with regulatory standards and restore confidence among stakeholders. As the situation unfolds, the financial community and regulators alike will be closely monitoring Morgan Stanley's strategy to mitigate risks associated with its wealth management practices. Featured Earnings 💰️ - JP Morgan Chase [JPM] ... AM - Wells Fargo [WFC] ... AM - Blackrock [BLK] ... AM - Citigroup [C] ... AM - State Street [STT] ... AM - Bank7 [BSVN] ... AM - Oncocyte [OCX] ... AM - KULR Technology Group [KULR] ... PM Economy 🏗 - Import price index [Mar] ... 8:30a - Consumer sentiment (prelim) [Apr] ... 10:00a Running Hot 🔥 Gainers - Beneficient [BENF] >> +71.4% - AMTD Digital [HKD] >> +24.2% - Trio Petroleum [TPET] >> +24.1% Decliners - Motus GI [MOTS] >> (37.4%) - Monogram Ortho [MGRM] >> (18.6%) - Rallybio [RLYB] >> (15.4%) Zapata Computing [ZPTA] - Last Close: $2.50 A late Thursday Schedule 13G/A disclosure from Wolverine Asset Management revealed the fund had taken a position in Zapata Computing. According to the filing, Wolverine’s position includes 76,789 shares of common stock, a minor position equaling less than a 0.1% ownership stake. ZPTA is up 27.6% on more than 6.5 million shares traded in response to the news. My Take: ZPTA is coming off a major pullback, but volume has begin to pick up in the past couple of days. It could be gearing up for a swing higher. PaxMedica [PXMD] - Last Close: $0.4119 In yesterday’s aftermarket, this tiny biotech announced the achievement of a key milestone and the development of its PAX-101 drug candidate. PaxMedica announced the completed execution of three pivotal registration batches of PAX-101, and it expects to submit a new drug application to the FDA in Q4 2024. PXMD is a top gainer with a 148.1% gain on more than 16 million shares traded. My Take: PXMD is getting a big boost from this news, but can it hold onto its gains? I imagine we’ll see a least a partial pullback before this move runs its course. NextPlat [NXPL] - Last Close: $1.50 NextPlat posted record-beating revenues of $49.7 million on its full-year 2024 financial report in Thursday’s aftermarket, and shares are soaring in response. The company’s full-year revenue figure marked a 22% increase from last year, and it improved its gross profit margin to 30% from 24% in 2022. NXPL is up 64.9% on more than 15 million shares traded. My Take: NXPL is making headway on sales, but a solid annual profit could still be a long way off. Allarity Therapeutics [ALLR] - Last Close: $2.30 Micro-cap biotech Allarity Therapeutics filed a prospectus summary that increased the price of stock included in an upcoming offering. Allarity said it has increased the price of offered shares from a max of $1.4 million to a max of $2.4 million. ALLR is up 30.8% in the wake of the announcement, with 3 million shares traded in ahead of the opening bell. My Take: ALLR is offering shares at a price of $8.56 per share, which is a big premium over its current price. Maybe the '‘Smart Money” knows something we dont. That's it for today! Thanks for reading, and good luck out there! Best Regards, — Chris D. Elite Trade Club Text ELITE to 47121 or [click here]( to get our alerts on your mobile device, and never miss another fast-moving stock! P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP. [Sign up for SMS]( [Privacy Policy]( | [Advertiser Disclosure]( [tw]( [ig]( [yt]( [tk]( *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. [Privacy Policy]( | [Terms of Service]( Update your email preferences or unsubscribe [here]( © 2024 Elite Trade Media LLC 1969 Alafaya Tr., Suite #247 Orlando, Florida 32828, United States of America [[beehiiv logo]Powered by beehiiv](

Marketing emails from elitetrade.club

View More
Sent On

08/12/2024

Sent On

07/12/2024

Sent On

06/12/2024

Sent On

06/12/2024

Sent On

03/12/2024

Sent On

03/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.